Cargando…
Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling
Breast cancer is a heterogeneous disease and patients are managed clinically based on ER, PR, HER2 expression, and key risk factors. The use of gene expression assays for early stage disease is already common practice. These tests have found a place in risk stratifying the heterogeneous group of sta...
Autores principales: | Aggarwal, S., Vaid, A., Ramesh, A., Parikh, Purvish M., Purohit, S., Avasthi, B., Gupta, S., Ranjan, S., Kaushal, V., Salim, S., Singh, R., Minhas, S., Doval, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909304/ https://www.ncbi.nlm.nih.gov/pubmed/29721472 http://dx.doi.org/10.4103/sajc.sajc_110_18 |
Ejemplares similares
-
Practical consensus recommendation on when to do BRCA testing
por: Parikh, Purvish M., et al.
Publicado: (2018) -
Practical consensus recommendations on Her2 +ve breast cancer with solitary brain mets
por: Rohatgi, Nitesh, et al.
Publicado: (2018) -
Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant)
por: Singhal, M., et al.
Publicado: (2018) -
Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
por: Bahl, A., et al.
Publicado: (2018) -
Practical consensus recommendations on management of triple-negative metastatic breast cancer
por: Rangarao, R., et al.
Publicado: (2018)